3E0U305
Introduction Joints to Other Antineoplastic with Antineoplastic, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 3 Administration |
| Body System | E Physiological Systems and Anatomical Regions |
| Operation | 0 Introduction |
| Body Part | U Joints |
| Approach | 3 Percutaneous |
| Device | 0 Antineoplastic |
| Qualifier | 5 Other Antineoplastic |
Operation Definition
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
Procedure Overview
Introduction covers putting a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance into or onto a body region, other than blood or blood products, which fall under Transfusion instead. This wide-ranging family includes things like injecting anesthesia, infusing chemotherapy, instilling contrast for imaging, delivering anti-infective medications, or providing nutritional formula through a feeding route.
Because it spans so many substance types and delivery sites, this is one of the most frequently used families in the Administration section. A patient might encounter it during an epidural injection, a course of intravenous antibiotics, contrast dye given before a CT scan, or tube feeding after surgery; each represents a substance being placed into the body to achieve a specific therapeutic or diagnostic goal rather than a physical alteration of tissue.
Anatomy & Axis Detail
Joints
Joints are introduced to substances when the goal is to act directly within the synovial space rather than relying on a drug's systemic distribution to reach cartilage and synovium efficiently. Corticosteroid injections reduce inflammation in osteoarthritis or inflammatory arthritis, viscosupplementation with hyaluronic acid aims to restore lubrication in a degenerated knee, and platelet-rich plasma or other biologic agents are increasingly used for tendon and joint pathology. Larger joints like the knee or shoulder are often accessed by palpation alone, while smaller or deeper joints such as the hip typically require fluoroscopic or ultrasound guidance to confirm intra-articular placement and avoid injecting into surrounding soft tissue. The specific joint injected determines the body part value, so the operative note should name it precisely.
Approach: Percutaneous
In Administration, Percutaneous denotes a substance delivered by needle injection through the skin, such as an intramuscular or subcutaneous injection, without cutting or scope guidance. It differs from External, where the substance is applied to the skin surface itself, and from Via Natural or Artificial Opening, where it is introduced through an orifice rather than through a puncture.
Substance: Antineoplastic
Antineoplastic designates administration of a substance intended to destroy or inhibit malignant cells, encompassing chemotherapy agents given systemically or regionally as part of cancer treatment. It is distinguished from Destructive Agent, which ablates tissue by direct chemical or physical action rather than targeted cytotoxic pharmacology, and from Radioactive Substance, which achieves its effect through ionizing radiation rather than chemical action.
Qualifier: Other Antineoplastic
A residual qualifier for antineoplastic agents administered under Administration that do not fit a named category such as monoclonal antibodies or specific chemotherapy classes. It captures cytotoxic or targeted cancer drugs lacking a dedicated code value. Coders reach for it only after confirming no more specific antineoplastic qualifier applies, distinguishing it from agent-specific entries like Clofarabine.
Coding & Documentation
Correct code assignment depends on identifying three things from the documentation: the substance given, matched to the correct qualifier value; the specific body region or route receiving it; and the approach used, such as percutaneous injection or an existing catheter. Physician orders and medication administration records are the primary support. The most common errors involve selecting an imprecise substance qualifier, for example coding a general anti-infective when the documentation specifies a particular drug category with its own value, or misidentifying the body region when a substance is delivered systemically versus locally, such as an intra-articular injection versus an intravenous one.
Commonly Confused With
This family is easily confused with Transfusion, but any blood or blood product is excluded here and must be coded under Transfusion instead, regardless of how it is delivered. It is also confused with routine medication administration that some facilities do not code separately when it is considered standard nursing care rather than a notable procedural event; coders should apply their facility's guidelines to determine which introductions rise to the level of a codable procedure.